Can robots like Roxy revolutionise cancer surgery in Scotland?
It is now more than five years since I first witnessed robot surgeons in action at the Golden Jubilee hospital in Clydebank.Surgeons say the contribution of robotic assisted surgery since then cannot be overstated.This week, First Minister John Swinney spoke at Scotland's National Robotarium to pledge that innovation and technology would be one of three key platforms for reforming the NHS. Artificial intelligence is the latest tool to assist with diagnostics, and a new digital app is promised to improve patient access. But what role might robots like Roxy play?
Robotic surgery has been expanding in Scotland since it was first introduced in Grampian in 2015. Companies such as Versius, Mako and Rosa have supplied robots to health boards to assist with specialties such as thoracic, urology and pancreatic surgery. More recently some hospitals are using robots for orthopaedics.In 2021, the Scottish government invested £20m purchasing 12 da Vinci robots, primarily to develop cancer surgery, particularly in areas such as womb cancer or bowel cancer, the specialisms with the highest rates of open surgery.Surgeons say robotic assisted surgery (RAS) is transforming their ability to perform delicate and complex cancer surgery - with faster recovery for patients.But so far RAS is responsible for only around 1% of the total number of operations carried out on the NHS in Scotland and further investment would be expensive, with the cost of a da Vinci robot in the region of £1.7m plus running costs.
Prof Graham Mackay is the clinical lead for the West of Scotland Cancer Centre and also a colorectal surgeon. He tells me that across Scotland they are seeing huge benefits from RAS. Rates of open surgery have dropped from about 70% to 30% in the past three years and it has almost halved the length of stay in hospital for patients, who also experience fewer complications.Prof Mackay says expanding the programme to other areas would help ease pressure on hospitals."There are still a number of hospitals that don't have this technology," he says. "There are other cancer types which we're not treating yet by this and certainly from what we've seen in bowel cancer, this has really been the biggest step forward in surgical care that I've seen during my career. "What we want is that for all cancer patients, where they can benefit from it, to be benefiting."
Isobel Morrison is one patient who has benefited from RAS. The 84-year-old required a hysterectomy to treat womb cancer but thanks to Roxy, was able to get home the day after her surgery in time to celebrate her 60th wedding anniversary.Isobel said: "I called him the Tin Man, and just said he'd done a good job. "I woke up, and didn't realise I'd even had it, "When the doctors happened to be in the ward, I said 'Excuse me, have I had my operation? And they said yes'. "So then I got home the next day, and I felt absolutely fine."
Back in surgery and Dr Burton's operation has reached a delicate stage. Lymph nodes are cut away, and, still inside the patient's body, they are neatly put into a bag that will be removed by theatre nurses through the vagina.Dr Burton says the robot is "fantastic" and has "massive advantages" over traditional open or keyhole surgery.He says: "Robotic surgery gives you a really immersed close-up view, a really steady view, and has a 3D element to the vision which allows you do really complex tasks."He says higher obesity rates have been directly linked to an increase in gynaecological cancers and robotic assisted surgery enables surgeons to operate on patients who are so overweight that they would previously have been considered inoperable.Dr Burton says that without doubt RAS has the potential to save money for the NHS."If we can get patients in hospital for less time, that frees up more beds for patients," he says. "So when you get a winter bed crisis, for example, we have more beds, we have more doctors and more nurses to actually deliver the care needed."
In 2021, with post-pandemic backlogs mounting, the government saw robots as playing a central role in the remobilisation of the NHS.But technology moves fast and ministers need to choose which innovations will deliver most impact for less cost, when health board budgets are under more pressure than ever.The current plans talk of better use of data to increase productivity as well as innovations in genetic testing to better target of medications.Digital support for mental health, dermatology and the management of long-term conditions is also planned as well as a new Scottish health and social care app.So who can say whether more Roxies are set to join Scotland's NHS robot surgery team?
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Record
an hour ago
- Daily Record
GP who wrote prescriptions for dead patients could be struck off as hearing set
John Henderson is due to go before the Medical Practitioners Tribunal Service (MPTS) after he faked prescriptions to administer powerful painkillers to himself. A disgraced doctor who wrote prescriptions in the names of dead patients for self-medication is due to face a professional tribunal that could see him struck off. John Henderson will go before the Medical Practitioners Tribunal Service (MPTS) on Monday, August 4, to determine whether his registration as a GP should be suspended or revoked following his conviction for obtaining prescription drugs by fraud. The 40-year-old was sentenced at Hamilton Sheriff Court last year after admitting to writing out prescriptions for powerful painkillers in his own name — and in the names of former patients, some of whom were deceased. Between July 2021 and February 2022, Henderson either collected the drugs himself from pharmacies or instructed NHS staff to pick them up and bring them to him. The shocking abuse of trust happened across Glasgow and Lanarkshire, involving multiple pharmacies and prescription forms. Henderson, who held a senior position with NHS Lanarkshire, claimed he suffered pain from a gall bladder condition and stress from working long night shifts during the pandemic. He escaped a prison sentence and was handed a community payback order including nine months of supervision and 100 hours of unpaid work to be completed within 12 months. He was also ordered to repay £883.02 in compensation. Now, the MPTS will assess whether Dr Henderson's fitness to practise has been impaired by his criminal behaviour, which involved serious breaches. According to pre-hearing documents, the tribunal will hear evidence that Dr Henderson 'presented the prescriptions to pharmacies, or instructed NHS staff to present them on his behalf and return the medication to him, thus obtaining the medication by fraud.' It was previously heard how NHS counter fraud became concerned about the out of hours GP who was suspected of prescribing drugs for himself. Investigations then uncovered a pattern of prescriptions being made for a strong painkiller called Oxycodone. Join the Daily Record WhatsApp community! Get the latest news sent straight to your messages by joining our WhatsApp community today. You'll receive daily updates on breaking news as well as the top headlines across Scotland. No one will be able to see who is signed up and no one can send messages except the Daily Record team. All you have to do is click here if you're on mobile, select 'Join Community' and you're in! If you're on a desktop, simply scan the QR code above with your phone and click 'Join Community'. We also treat our community members to special offers, promotions, and adverts from us and our partners. If you don't like our community, you can check out any time you like. To leave our community click on the name at the top of your screen and choose 'exit group'. If you're curious, you can read our Privacy Notice. Investigators linked the paperwork to Henderson and NHS delivery drivers later said they had been asked to make unusual collections from pharmacies on his instruction. In June 2022 a search of his home found needles and drugs and he was arrested. Henderson's lawyer said in court he was deeply sorry for his actions which had been driven by stress and medical issues. The father-of-two has since been living in England with his family. NHS Lanarkshire previously confirmed that immediate steps were taken when the allegations first came to light, including reporting the matter to police and working with relevant medical authorities. If the tribunal finds his actions amount to serious professional misconduct, Dr Henderson could be suspended or struck off the medical register entirely. The MPTS hearing is expected to take place from August 4 to 12.
Telegraph
an hour ago
- Telegraph
Millions on NHS waiting lists yet to have first appointment
Millions of people in England on NHS waiting lists are yet to have their first appointment, new data reveal. Figures from NHS England last month suggest nearly half of those waiting for hospital care have not had their first appointment with a specialist or a diagnostic test since their GP referral. An analysis by health data specialist MBI Health suggests nearly three million out of the 6.23 million patients (48 per cent) waiting for treatment are left in limbo. Experts referred to the issue as a 'frontlog' and warned the crisis 'has gone unchallenged for too long'. MBI's analysis also found that around 70 per cent of referral-to-treatment pathways fall into the category of being 'unseen' since the patient's GP referred them to a specialist. Delays in making a first assessment can lead to late diagnosis, worsening symptoms and pressure on emergency services. The analysis found that ear, nose and throat, trauma and orthopaedics, gastroenterology, ophthalmology and gynaecology and obstetrics departments were consistently the specialist departments with the greatest number of patients not seen for the first time. 'That's a breakdown' As part of the Government's 10-year health plan, the NHS is expected to meet its target of carrying out 92 per cent of routine operations and appointments within 18 weeks by March 2029 – a target that has not been achieved for almost a decade. The latest figures show how challenging that target will be given an estimated one million of the three million unseen patients have already gone more than 18 weeks without receiving any care. 'If accurate, three million people are trapped in an invisible waiting-list crisis, stuck without basic diagnostic tests of first appointments while their conditions worsen,' Rachel Power, the chief executive of the Patients Association, told the Guardian. 'The scale is staggering, as nearly half of all patients on a waiting list haven't been seen by anyone. That's not a healthcare service; that's a breakdown. 'These aren't just statistics. They're people checking their phones daily for hospital calls that never come, unable to plan their lives while their symptoms deteriorate.' Last month it was found people of working age are making up a growing proportion of those on the NHS waiting list for treatment in England. Data tables published for the first time by NHS England also show people in the most deprived parts of the country are more likely to wait more than a year to start hospital treatment than those in the least deprived. The figures, analysed by the PA news agency, showed 56.1 per cent of those on the list at the end of June this year were of working age (defined as age 19 to 64), up from 55.8 per cent a year ago and 55 per cent in June 2022. At the same time, the proportion of people on the waiting list under the age of 19 has fallen, standing at 10.8 per cent in June this year, down from 11.2 per cent a year earlier and 11.9 per cent in June 2022. The proportion who are over 65 has remained broadly unchanged at around 33.1 per cent. People of working age are also more likely to have to wait more than a year to start treatment (three per cent of patients in this age group at the end of June) than those over 65 (two and half per cent). However, the proportion is the same as those under 19 (also three per cent). An NHS spokesman said: 'NHS staff have made significant progress in reducing waiting lists in the last year, which are down by more than 260,000 since June 2024. 'All patients are assessed by clinicians as they are added to waiting lists, and we will continue with our plan to improve waiting times for patients throughout the year.'
South Wales Argus
an hour ago
- South Wales Argus
Over-the-counter medicines could fail for Brits due to DNA
The trial saw 2,200 adults undergo whole genome sequencing to analyse how their individual DNA responds to the likes of antibiotics and over-the-counter painkillers. A staggering 99% showed a genetic variant that affects their sensitivity to certain medicines. This could mean some drugs, including over-the-counter, everyday painkillers, antibiotics and other prescription medications, won't work for some people based on their individual DNA. DNA could stop over-the-counter medicines working for some Brits The blood test, part of Bupa's My Genomic Health scheme, also looked into their genetic risk of developing 36 preventable diseases, including cancers, heart conditions and type 2 diabetes. It found 91% of participants were found to be at risk of developing a disease with genetic and lifestyle risk factors, such as fatty liver disease, breast cancer and certain heart diseases. While 73% had multiple genetic variants that put them at raised risk of developing a condition that could be prevented or detected early, leading to better health outcomes, including the likes of high cholesterol, skin cancer and type 2 diabetes. Of the participants, 49% were found to be carriers of a genetic variant that could lead to a raised risk of a certain condition in future generations. How to get your own Medication Check Following the successful pilot, Medication Check can now be purchased through Bupa and will also be available to more than three million of its customers as part of its workplace health scheme. A saliva test will establish what medications are most likely to be effective, those with increased risk of adverse side effects, or ones that won't work for you at all. When to see your GP about cancer Dr Rebecca Rohrer, clinical innovation and genomics director for Bupa, said: 'We've long known that most medications only work for 30-50% of the population. 'However, this pilot has highlighted just how significantly individual genomes impact the effectiveness of medications in treating conditions. 'With more than half of us regularly taking a prescription medication and an increasing number affected by a chronic condition, it's crucial that people are prescribed the right medicine from the start, tailored to their unique genetic makeup. 'In the longer term, genomics is key to early detection and even preventing some illnesses altogether.' Today is World Lung Cancer Day. Contact your GP practice if you are experiencing any of these signs and symptoms of lung cancer. It's probably nothing serious, but early diagnosis and treatment can save lives. Find out more at — NHS (@NHSuk) August 1, 2025 After completing the at-home medication check, patients will be offered a GP consultation with the healthcare provider to review any medication identified in their genetic tests. It comes as Bupa is about to introduce two new products to its My Genomic Health suite later this year that will help to prevent or detect illness earlier. The DNA Health Check will give people early warning of an increased genetic risk of four different conditions - breast cancer, prostate cancer, type 2 diabetes and cardiovascular disease. While the Advanced DNA Health Check will combine insights from medication, disease risk, carrier status and traits, and will look at the genetic risk of developing conditions such as heart disease, metabolic disease and 10 types of cancer. Recommended reading: Carlos Jaureguizar, CEO for Bupa Global, India & UK, said: 'Whole genomic sequencing is fundamentally changing our approach to healthcare, pivoting from treatment to prevention. 'It has the power to become a health passport that people can reference throughout their lives. 'We firmly believe genomics is the path to health innovation and prevention, reducing the nation's health burden and giving people personalised knowledge of their own genomic profile to live well for longer.'
